Charles Schwab’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69M | Buy |
1,775,566
+473,483
| +36% | +$1.25M | ﹤0.01% | 2357 |
|
|
2025
Q1 | $3.92M | Buy |
1,302,083
+25,410
| +2% | +$76.5K | ﹤0.01% | 2377 |
|
|
2024
Q4 | $3.27M | Buy |
1,276,673
+10,692
| +0.8% | +$27.4K | ﹤0.01% | 2524 |
|
|
2024
Q3 | $4.71M | Buy |
1,265,981
+29,665
| +2% | +$110K | ﹤0.01% | 2402 |
|
|
2024
Q2 | $7.81M | Buy |
1,236,316
+65,104
| +6% | +$411K | ﹤0.01% | 2154 |
|
|
2024
Q1 | $6.29M | Buy |
1,171,212
+28,287
| +2% | +$152K | ﹤0.01% | 2204 |
|
|
2023
Q4 | $5.74M | Buy |
1,142,925
+92,991
| +9% | +$467K | ﹤0.01% | 2248 |
|
|
2023
Q3 | $1.77M | Buy |
1,049,934
+71,387
| +7% | +$121K | ﹤0.01% | 2634 |
|
|
2023
Q2 | $2.72M | Buy |
978,547
+262,912
| +37% | +$731K | ﹤0.01% | 2456 |
|
|
2023
Q1 | $1.3M | Sell |
715,635
-7,884
| -1% | -$14.3K | ﹤0.01% | 2647 |
|
|
2022
Q4 | $3.67M | Buy |
723,519
+11,301
| +2% | +$57.3K | ﹤0.01% | 2365 |
|
|
2022
Q3 | $3.54M | Buy |
712,218
+237,948
| +50% | +$1.18M | ﹤0.01% | 2394 |
|
|
2022
Q2 | $1.77M | Sell |
474,270
-18,789
| -4% | -$69.9K | ﹤0.01% | 2606 |
|
|
2022
Q1 | $2.77M | Buy |
493,059
+16,672
| +3% | +$93.6K | ﹤0.01% | 2538 |
|
|
2021
Q4 | $2.9M | Buy |
476,387
+18,182
| +4% | +$111K | ﹤0.01% | 2574 |
|
|
2021
Q3 | $4.46M | Sell |
458,205
-33,654
| -7% | -$328K | ﹤0.01% | 2426 |
|
|
2021
Q2 | $7.02M | Buy |
491,859
+234,631
| +91% | +$3.35M | ﹤0.01% | 2186 |
|
|
2021
Q1 | $6.11M | Buy |
257,228
+3,780
| +1% | +$89.7K | ﹤0.01% | 2195 |
|
|
2020
Q4 | $3.38M | Sell |
253,448
-1,777
| -0.7% | -$23.7K | ﹤0.01% | 2405 |
|
|
2020
Q3 | $1.77M | Buy |
255,225
+49,222
| +24% | +$341K | ﹤0.01% | 2532 |
|
|
2020
Q2 | $2.53M | Buy |
206,003
+37,948
| +23% | +$466K | ﹤0.01% | 2336 |
|
|
2020
Q1 | $484K | Buy |
168,055
+3,352
| +2% | +$9.65K | ﹤0.01% | 2724 |
|
|
2019
Q4 | $625K | Buy |
164,703
+37,660
| +30% | +$143K | ﹤0.01% | 2737 |
|
|
2019
Q3 | $155K | Buy |
127,043
+46,514
| +58% | +$56.8K | ﹤0.01% | 3068 |
|
|
2019
Q2 | $83K | Sell |
80,529
-55,934
| -41% | -$57.7K | ﹤0.01% | 3131 |
|
|
2019
Q1 | $216K | Buy |
136,463
+2,686
| +2% | +$4.25K | ﹤0.01% | 3007 |
|
|
2018
Q4 | $156K | Sell |
133,777
-2,584
| -2% | -$3.01K | ﹤0.01% | 3046 |
|
|
2018
Q3 | $505K | Buy |
136,361
+14,653
| +12% | +$54.3K | ﹤0.01% | 2835 |
|
|
2018
Q2 | $373K | Buy |
121,708
+3,741
| +3% | +$11.5K | ﹤0.01% | 2890 |
|
|
2018
Q1 | $459K | Buy |
117,967
+3,393
| +3% | +$13.2K | ﹤0.01% | 2756 |
|
|
2017
Q4 | $515K | Buy |
114,574
+4,524
| +4% | +$20.3K | ﹤0.01% | 2715 |
|
|
2017
Q3 | $604K | Buy |
110,050
+4,891
| +5% | +$26.8K | ﹤0.01% | 2663 |
|
|
2017
Q2 | $799K | Buy |
105,159
+53,134
| +102% | +$404K | ﹤0.01% | 2535 |
|
|
2017
Q1 | $185K | Sell |
52,025
-24,492
| -32% | -$87.1K | ﹤0.01% | 2938 |
|
|
2016
Q4 | $438K | Buy |
76,517
+4,928
| +7% | +$28.2K | ﹤0.01% | 2700 |
|
|
2016
Q3 | $557K | Buy |
71,589
+31,836
| +80% | +$248K | ﹤0.01% | 2576 |
|
|
2016
Q2 | $248K | Buy |
39,753
+19,878
| +100% | +$124K | ﹤0.01% | 2859 |
|
|
2016
Q1 | $164K | Buy |
19,875
+459
| +2% | +$3.79K | ﹤0.01% | 2938 |
|
|
2015
Q4 | $337K | Buy |
19,416
+8,985
| +86% | +$156K | ﹤0.01% | 2820 |
|
|
2015
Q3 | $120K | Buy |
+10,431
| New | +$120K | ﹤0.01% | 3015 |
|